Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 08 symbols : Snynf save search
Denali Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.73%
H: 0.53%
C: -0.84%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 1.03%
H: 7.14%
C: 3.13%
therapeutics results
IGM Biosciences Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
IGMS | $7.73 14.52% 12.68% 410K
|
Health Technology
|
| O: 1.11%
H: 9.93%
C: 8.57%
update results
Sanofi: Information concerning the total number of voting rights and shares – July 2022
Published: 2022-08-08 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -0.59%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
Global Oncology Drugs Market to Surpass US$ 301.8 Billion by 2030 - Coherent Market Insights
Published: 2022-08-08 (Crawled : 18:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 4.04%
H: 0.0%
C: 0.0%
MCK | $532.0 0.89% 0.0% 380K
|
Distribution Services
|
| O: 0.07%
H: 0.84%
C: 0.12%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.22%
H: 1.82%
C: 0.62%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.53%
H: 0.49%
C: -0.85%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.51%
H: 1.12%
C: 0.93%
global market
Insulin Market Size Worth $111.21 Billion by 2028 at 10.8% CAGR Lead by Biosimilar Insulin Segment (Register 16% CAGR) Global Analysis by The Insight Partners
Published: 2022-08-08 (Crawled : 12:00) - prnewswire.com
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: -0.62%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.22%
H: 1.82%
C: 0.62%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
global biosimilar insulin market
Global Genital Herpes Treatment Markets, 2022-2027 - Promising Investigational Therapies for Treating Genital Herpes
Published: 2022-08-08 (Crawled : 11:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
treatment global
BioNTech Announces Second Quarter 2022 Financial Results and Corporate Update
Published: 2022-08-08 (Crawled : 11:00) - biospace.com/
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 1.97%
H: 0.56%
C: -2.26%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -0.09%
H: 0.83%
C: 0.26%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -8.8%
H: 2.35%
C: 1.38%
MTNB | $0.1815 0.83% -0.61% 770K
|
Health Technology
|
| O: -3.3%
H: 5.11%
C: 5.11%
update results
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer
Published: 2022-08-08 (Crawled : 01:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
global
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema
Published: 2022-08-08 (Crawled : 01:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.22%
H: 1.82%
C: 0.62%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.0%
H: 2.7%
C: 2.55%
ibi324 macular study diabetic phase 1
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.